[HTML][HTML] Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
JJ Meier, A Gethmann, O Götze, B Gallwitz… - Diabetologia, 2006 - Springer
Aims/hypothesis Diabetic dyslipidaemia contributes to the excess morbidity and mortality in
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
[PDF][PDF] Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
JJMAGO Götze, B Gallwitz, JJHWESMA Nauck - Diabetologia, 2006 - researchgate.net
Aims/hypothesis: Diabetic dyslipidaemia contributes to the excess morbidity and mortality in
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
[引用][C] Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
M JJ - Diabetologia, 2006 - cir.nii.ac.jp
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and
lowers levels of non-esterified fatty acids in humans | CiNii Research CiNii 国立情報学研究所 …
lowers levels of non-esterified fatty acids in humans | CiNii Research CiNii 国立情報学研究所 …
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
JJ Meier, A Gethmann, O Götze, B Gallwitz, JJ Holst… - Diabetologia, 2006 - infona.pl
Aims/hypothesis Diabetic dyslipidaemia contributes to the excess morbidity and mortality in
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
JJ Meier, A Gethmann, O Götze, B Gallwitz… - …, 2006 - search.proquest.com
Diabetic dyslipidaemia contributes to the excess morbidity and mortality in patients with type
2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers postprandial glycaemia …
2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers postprandial glycaemia …
[PDF][PDF] Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
JJMAGO Götze, B Gallwitz, JJHWESMA Nauck - Diabetologia, 2006 - academia.edu
Aims/hypothesis: Diabetic dyslipidaemia contributes to the excess morbidity and mortality in
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.
JJ Meier, A Gethmann, O Götze, B Gallwitz, JJ Holst… - Diabetologia, 2006 - europepmc.org
Methods 14 healthy male volunteers were studied with an iv infusion of GLP-1 (1.2 pmol kg (-
1) min (-1)) or placebo over 390 min in the fasting state. A solid test meal was served and …
1) min (-1)) or placebo over 390 min in the fasting state. A solid test meal was served and …
[引用][C] Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
JJ MEIER, A GETHMANN, O GÖTZE… - Diabetologia …, 2006 - pascal-francis.inist.fr
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and
lowers levels of non-esterified fatty acids in humans CNRS Inist Pascal-Francis CNRS …
lowers levels of non-esterified fatty acids in humans CNRS Inist Pascal-Francis CNRS …
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.
JJ Meier, A Gethmann, O Götze, B Gallwitz, JJ Holst… - 2006 - cabidigitallibrary.org
Aims/hypothesis: Diabetic dyslipidaemia contributes to the excess morbidity and mortality in
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …
patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers …